Highlights from the Movement Disorder Society Virtual Congress 2021

Posted on by Rebecca Gilbert, MD, Ph.D.

  Every year the International Parkinson and Movement Disorder Society (MDS) holds a conference and every year APDA is...see more there, learning about the newest research and sharing our resources with the wider Parkinson’s disease (PD) community. The MDS Congress is the preeminent gathering of medical professionals from around the world who are dedicated to PD […]

Read More

New and innovative Parkinson’s disease research being funded by APDA

Posted on by Rebecca Gilbert, MD, Ph.D.

NEW, INNOVATIVE PARKINSON’S DISEASE RESEARCH BEING FUNDED BY APDA On September 1, 2021, APDA announced our research grantees for...see more the year ahead. Our grant recipients are working tirelessly to understand the complexities of Parkinson’s disease in an effort to develop new treatments and eventually, a cure, and we are honored to support their work. This […]

Read More

How Parkinson’s Disease Researchers Get Funding for Their Work

Posted on by Rebecca Gilbert, MD, Ph.D.

Learn more about how Parkinson’s research grant proposals are created, from inception to submission to APDA Every May, APDA’s...see more Scientific Advisory Board  (SAB) meets to choose the research grants that APDA will fund in the upcoming fiscal year. APDA’s SAB is comprised of highly successful scientists with a broad range of backgrounds and expertise in […]

Read More

Preventing the Accumulation of alpha-synuclein: An Interview with ADPA Researcher, Dr. April Darling

Posted on by Rebecca Gilbert, MD, Ph.D.

Meet Dr. April Darling, an APDA-funded researcher studying methods to reduce alpha-synuclein in the brains of people with Parkinson’s...see more disease. Our A Closer Look blog is designed to educate, inform, and inspire you through a variety of topics and insights about Parkinson’s disease (PD). One way we do that is through our Interview with APDA Researchers series, as a […]

Read More

Highlights from the 2021 AAN Annual Meeting

Posted on by Rebecca Gilbert, MD, Ph.D.

The Latest in Parkinson’s Research from AAN 2021 The American Academy of Neurology (AAN) is the preeminent professional association...see more for neurologists in the US dedicated to supporting and improving the profession of neurology. Every year, AAN holds an annual conference at which new data on all aspects of neurology, including Parkinson’s disease (PD), is presented. […]

Read More

Where are they now? APDA’s research success continued

Posted on by Rebecca Gilbert, MD, Ph.D.

Q & A with APDA research grant recipients Since 1961, APDA has been a funding partner in many major...see more scientific breakthroughs and has awarded more than $51 million in research grants to date. APDA funds individual research grants and fellowships to scientists performing innovative Parkinson’s disease (PD) research. Grants are awarded through a competitive application […]

Read More

Neuroinflammation in Parkinson’s disease: An Interview with ADPA Researcher, Dr. Edward Griffin

Posted on by Rebecca Gilbert, MD, Ph.D.

Dr. Edward Griffin researches the relationship between neuroinflammation and Parkinson’s disease Today we introduce you to Dr. Edward Griffin, a...see more post-doctoral fellow at the University of Alabama at Birmingham. He is the recipient of a 2019-2020 APDA Post-doctoral fellowship and is currently studying the role of inflammation in the development of Parkinson’s disease (PD). We asked […]

Read More

PD and the microbiome

Posted on by Rebecca Gilbert, MD, Ph.D.

What is the microbiome? The human gut harbors trillions of micro-organisms referred to collectively as the microbiome. Current understanding...see more is that the microbiome provides a number of benefits to the human including help with digestion of food, help with warding off harmful microorganisms, aid in the absorption of particular nutrients, and creation of needed vitamins. […]

Read More

Therapies for non-motor symptoms of Parkinson’s disease in clinical trials

Posted on by Rebecca Gilbert, MD, Ph.D.

The pipeline for Parkinson’s disease (PD) medications is extremely crowded these days, with multiple medications at various stages of...see more research and development. Currently most of the approved medications for PD address the motor symptoms of PD – tremor, slowness, stiffness, and walking difficulties. Medications are also available to help people overcome OFF time or improve […]

Read More